Kato K, Muro K, Minashi K, et al: Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II - III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys 81 : 684-690, 2010
Kato H, Sato A, Fukuda H, et al: A PhaseII Trial of Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 39: 638-643, 2009
Kato K, Nakajima T, Ito Y, et al: Phase II study of concurrent chemoradiotherapy at the dose of 50.4Gy with elective nodal irradiation for Stage II-III esophageal carcinoma. Jpn J Clin Oncol 43 : 608-615, 2013
Minsky BD, Pajak TF, Ginsberg RJ, et al: INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer high-dose versus standard-dose radiation therapy. J Clin Oncol 20: 1167-1174, 2002
Tahara M, Fuse N, Mizusawa J, et al: Phase I / II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II / III esophageal carcinoma (JCOG 0604). Cancer Sci 106 : 1414-1420, 2015